Difference between revisions of "Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 82 in DOI:10.1007/s11886-020-01292-3 (Q10591)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: First Author string (P149): Gautret P, #quickstatements; #temporary_batch_1592502690680)
(‎Added link to [sliswiki]: Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 82 in DOI:10.1007/s11886-020-01292-3, #quickstatements; #temporary_batch_1592946843269)
 
(7 intermediate revisions by the same user not shown)
Property / Second Author string
 +
Lagier J-C
Property / Second Author string: Lagier J-C / rank
 +
Normal rank
Property / Third Author string
 +
Parola P
Property / Third Author string: Parola P / rank
 +
Normal rank
Property / Fourth Author string
 +
Hoang VT
Property / Fourth Author string: Hoang VT / rank
 +
Normal rank
Property / Fifth Author string
 +
Meddeb L
Property / Fifth Author string: Meddeb L / rank
 +
Normal rank
Property / Sixth Author string
 +
Mailhe M
Property / Sixth Author string: Mailhe M / rank
 +
Normal rank
Property / Publication Date
 +
2020
Timestamp+2020-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2020 / rank
 +
Normal rank
Property / Published In Name String
 +
Int J Antimicrob Agents
Property / Published In Name String: Int J Antimicrob Agents / rank
 +
Normal rank
links / sliswiki / namelinks / sliswiki / name
 +

Latest revision as of 21:15, 23 June 2020

Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
Language Label Description Also known as
English
Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 82 in DOI:10.1007/s11886-020-01292-3
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.

    Statements

    Q10356 (Deleted Item)
    0 references
    Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;105949. (English)
    0 references
    Gautret P
    0 references
    Lagier J-C
    0 references
    Parola P
    0 references
    Hoang VT
    0 references
    Meddeb L
    0 references
    Mailhe M
    0 references
    2020
    0 references
    Int J Antimicrob Agents
    0 references